Home Cart 0 Sign in  

[ CAS No. 75178-87-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 75178-87-9
Chemical Structure| 75178-87-9
Structure of 75178-87-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 75178-87-9 ]

Related Doc. of [ 75178-87-9 ]

Alternatived Products of [ 75178-87-9 ]

Product Details of [ 75178-87-9 ]

CAS No. :75178-87-9 MDL No. :MFCD01861334
Formula : C9H19NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :LIYMTLVBAVHPBU-UHFFFAOYSA-N
M.W : 189.25 Pubchem ID :545141
Synonyms :

Calculated chemistry of [ 75178-87-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.89
Num. rotatable bonds : 7
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 51.05
TPSA : 58.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.42
Log Po/w (XLOGP3) : 0.96
Log Po/w (WLOGP) : 1.28
Log Po/w (MLOGP) : 0.95
Log Po/w (SILICOS-IT) : 0.79
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.16
Solubility : 13.2 mg/ml ; 0.0698 mol/l
Class : Very soluble
Log S (Ali) : -1.78
Solubility : 3.16 mg/ml ; 0.0167 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.88
Solubility : 2.51 mg/ml ; 0.0132 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.06

Safety of [ 75178-87-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 75178-87-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 75178-87-9 ]
  • Downstream synthetic route of [ 75178-87-9 ]

[ 75178-87-9 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 75178-87-9 ]
  • [ 68076-36-8 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1996, # 8, p. 2143 - 2161
  • 2
  • [ 13325-10-5 ]
  • [ 24424-99-5 ]
  • [ 75178-87-9 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine In acetonitrile at 0℃; for 6.5 h; Inert atmosphere 4-amino-1-butanol (0.5 g, 5.61 mmol) was dissolved in acetonitrile (56 ml). The solution was cooled to 0°C and Et3N (1.56 ml, 11.22 mmol, 2 eq.) was added followed by Boc2O (1.346 g, 6.17 mmol). The reaction was followed by TLC and quenched with water (20 ml) after 6.5 h. The solution was extracted with EtOAc (3x30ml), brine was used to help phase separation. The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel (CH2Cl2/MeOH, 95:5) to give the title compound as a colorless oil (1.06 g, quantitative yield)
100% With triethylamine In methanol at 0 - 20℃; To the solution of 4-aminobutanol (100 μL) in 2 mL triethylamine/methanol (Et3N/MeOH, v/v, 1:7) di-tert-butyl dicarbonate (278 μL) in 2.5 mL methanol was added dropwise at 0 °C. The solution was stirred at the same temperature overnight and allowed to warm to room temperature during 2 h and kept at ambient temperature for another 6 h. Upon completion of the reaction monitored by TLC visualized by iodine and ninhydin, excess Boc2O and solvent were removed under vacuum. The residue was partitioned between dichloromethane (CH2Cl2) and brine and extracted with CH2Cl2 (3 * 50 mL). The combined organic layers were washed by brine, then dried over MgSO4, filtered and concentrated in vacuo to provide tert-butyl N-(4-hydroxybutyl)carbamate 2 as colorless oil (152 mg, 100percent).
1H NMR (300 MHz, CDCl3) δ 5.02 (s, 1H), 3.63 (t, J = 6.1 Hz, 2H), 3.40 (s, 1H), 3.13 (d, J = 5.9 Hz, 2H), 1.56 (dd, J = 7.2, 4.1 Hz, 4H), 1.44 (s, 9H).
100% at 20℃; for 3 h; Butanolamine (5g, 56.09 mmol, 1.0 eq) is introduced in a round-bottomed flask with THF (20 mL) before dropwise addition of di-tert-butylcarbonate (12 mL, 56.09 mmol, 1.0 eq) in THF (10 mL). The reaction mixture is stirred at room temperature for 3 h. After concentration under vacuum, the desired product is obtained as an amorph solid that crystalize upon standing (10 g, quantitative yield).
100% at 20℃; for 3 h; To a solution of 4-amino-1 -butanol (2.0 g, 22.5 mmole) in THF at RT was added Boc anhydride (4.90 g, 22.5 mmole). After 3 h, the reaction solution was concentrated under vacuum and the residue purified on silica gel (hexanes/EtOAc, 1 :1 ) to give the title compound (quant.) as a white solid: LCMS (ES) m/z = 190 (M+H)+
96% With sodium hydroxide In 1,4-dioxane; water at 20℃; for 12 h; General procedure: To a solution of 2a (or 2b–e, 20 mmol) in a mixture of dioxane (15 mL) and H2O (7 mL), wasadded 5N NaOH (4.8 mL) and a solution of Boc2O (5.0 g, 23 mmol) in dioxane at 0 °C. After stirred atrt overnight, the reaction mixture was concentrated in vacuo. The residue was extracted from 10percentcitric acid with AcOEt, and dried over anhydrous Na2SO4. Evaporation of the solvents gave the pureproduct 3a–e. 3a was obtained as a colorless oil (2.67 g, 83percent).
90.2% at 0℃; for 4 h; General procedure: tert-butyl 3-hydroxypropylcarbamate 13a: Boc anhydride(319.2g, 1.46 mol) was added drop wise to 3-aminopropan-1-ol (100.0g, 1.33mol) in methanol ( 1000ml )at 0 °C. Reaction mixture was allowed to stir for 4hr. Reaction mixture was concentrated and diluted with water(1000ml) and ethylacetate (1000ml). Layers were separated.Organic layer was washed with water (250ml), dried oversodium sulfate and concentrated. 202.3g of clear liquid was obtained with 87percent yield. tert-butyl 4-hydroxybutylcarbamate 13b: Followingthe same procedure for 13a, 191.5g of clear liquid with90.2percent yield was obtained. 1H NMR (CDCl3) = 1.44 (s, 9H), 1.48(s, 1 H), 1.52-1.59 (m, 4 H), 3.12-3.16 (m, 2H,),3.66-3.68 (m, 2 H), 4.60-4.69 (br, s, 1 H), 13C NMR (CDCl3)= 26.61, 28.44, 29.74, 40.34, 62.31, 79.21, 156.22.
90.5% With triethylamine In dichloromethane at 20℃; for 12 h; 4-amino-1-butanol (40) (2.97 g) and triethylamine (5 mL) were added to dichloromethane (60ML), di-tert-butyl dicarbonate (6.61 g) was added under ice-cooling, and the mixture was stirred for 5 minutes. reactionThe solution was returned to room temperature and stirred for 12 hours.Under ice cooling, a 1 N hydrochloric acid aqueous solution was added to the reaction solution and further diluted with dichloromethane. After separating the organic layer, the obtained organic layer was washed with saturated brine and dried with anhydrous sodium sulfate. Filtration and concentration under reduced pressure gave the title compound (41) (5.71 g, yield 90.5percent) as a pale yellow oil.
89% at 20℃; for 1.5 h; N-tert-Butoxycarbonyl-4-amino-1-butanol 4-Amino-1-butanol (1.0 g, 11.22 mmol) was dissolved in methanol (10 ml). To this solution, di-tert-butyl carbonate (2.53 g, 11.58 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. After the reaction was confirmed by TLC to be complete, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (hexane:acetone=9:1) to obtain N-tert-butoxycarbonyl-4-amino-1-butanol (1.88 g, yield: 89percent).
88% With triethylamine In dichloromethane at 20℃; for 2 h; To a mixture of 4-aminobutan-l-ol (4.0 g, 45 mmol) and TEA (7.5 mL, 54 mmol) in DCM (200 ml) was added (Boc)20 (10.2 g, 47.2 mmol). The reaction mixture was stirred for 2 h at room temperature and then washed with water (2x150 mL) and the solution of citric acid (100 mL). The organic layer was dried over anhydrous Na2S04 and concentrated to give the product as yellow oil 7.5 g. (yield 88percent).
82% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 1.5 h; 4-Aminobutan-1-ol (1.0 g, 11.2 mmol) was suspended in a mixture of dioxane (20 ml), H2O (10 ml) and 1 M NaOH (10 ml) and cooled to 0 °C (ice-water bath) with stirring. Boc2O (2.69 g, 12.34 mmol) was added and stirring was continued at ambient temperature. After 5.5 h additional Boc2O (1.08 g, 4.95 mmol) was added and stirring was continued overnight. Next day additional Boc2O (1.35 g, 6.19 mmol) was added to the suspension. After 1.5 h sulfate buffer (40 ml) was added and the reaction mixture was transferred to a separating funnel and extracted with EtOAc (3 × 30 ml). The combined organic layers were washed with NaHCO3(90 ml) and brine (90 ml), dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash column chromatography (60 percent EtOAc in n-heptane, v/v) gave carbamate 4 (1.62 g, 82percent) as a colourless oil.
54% With N-ethyl-N,N-diisopropylamine In 1,2-dichloro-ethane at 20℃; for 24 h; Inert atmosphere A mixture of 4-aminobutan-1-ol (10.0 g, 112.1 mmol, 10.4 mL, 1.0 eq), tert- butoxycarbonyl tert-butyl carbonate (25.7 g, 117.8 mmol, 27.1 mL, 1.05 eq) and DIEA (21.7 g, 168.2 mmol, 29.3 mL, 1.5 eq) in DCE (400 mL) was stirred at 20 °C for 24 h, diluted with water (400 mL) and extracted with DCM (100 mL*3). The combined organic layers were washed with brine (100 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2) to give compound 07-4-1 (12.0 g, 60.2 mmol, 54percent yield).1H NMR (CDCl3, 400 MHz): δ 3.67 (d, J=4.85 Hz, 2 H), 3.16 (d, J=5.29 Hz, 2 H), 1.54 - 1.62 (m, 4 H), 1.44 (s, 9 H).
7.54 g at 20℃; for 24 h; Cooling with ice Reference Example 35 tert-Butyl 4-hydroxybutylcarbamate (0486) (0487) To a mixture of 4-aminobutanol (3.57 g) and ethyl acetate (9 mL) was dropwise added a mixture of di-tert-butyl dicarbonate (8.73 g) and ethyl acetate (1 mL) under ice-cooling. After stirring at room temperature for 24 hrs., the mixture was concentrated under reduced pressure. The residue was dissolved in ethyl acetate (200 mL), and the mixture was washed with water (50 mL), 1N hydrochloric acid (40 mL), water (30 mL) and saturated brine (30 mL) and dried over anhydrous magnesium sulfate. Concentration under reduced pressure gave the title compound (7.54 g) as a colorless oil. (0488) 1H-NMR(CDCl3): 1.44 (9H, s), 1.47-1.61 (4H, m), 3.07-3.22 (2H, m), 3.61-3.76 (2H, m), 4.62 (1H, bs).

Reference: [1] Organic Letters, 2009, vol. 11, # 9, p. 2019 - 2022
[2] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 6, p. 2536 - 2543
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1151 - 1155
[4] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 2, p. 191 - 200
[5] Inorganica Chimica Acta, 2016, vol. 452, p. 152 - 158
[6] Patent: WO2006/113837, 2006, A2, . Location in patent: Page/Page column 78
[7] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 8, p. 803 - 808
[8] Chemistry - A European Journal, 2016, vol. 22, # 9, p. 3009 - 3018
[9] Synthesis, 1990, p. 366 - 368
[10] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 23, p. 7050 - 7053
[11] Synthesis, 2011, # 24, p. 3991 - 3996
[12] Tetrahedron Letters, 2008, vol. 49, # 29-30, p. 4491 - 4493
[13] Journal of Medicinal Chemistry, 2009, vol. 52, # 22, p. 7029 - 7043
[14] Tetrahedron Letters, 1998, vol. 39, # 32, p. 5697 - 5700
[15] Bioorganic Chemistry, 2002, vol. 30, # 2, p. 81 - 94
[16] Angewandte Chemie - International Edition, 2012, vol. 51, # 32, p. 8110 - 8113
[17] Molecules, 2013, vol. 18, # 11, p. 13957 - 13978
[18] Journal of Medicinal Chemistry, 2014, vol. 57, # 11, p. 4924 - 4939
[19] Journal of Medicinal Chemistry, 2015, vol. 58, # 13, p. 5287 - 5307
[20] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4183 - 4195
[21] Farmaco, 1991, vol. 46, # 12, p. 1517 - 1529
[22] Letters in Organic Chemistry, 2013, vol. 10, # 7, p. 518 - 522
[23] Patent: JP2017/71567, 2017, A, . Location in patent: Paragraph 0208-0210
[24] Patent: US2015/353489, 2015, A1, . Location in patent: Paragraph 0070; 0181; 0182
[25] Patent: WO2012/33858, 2012, A2, . Location in patent: Page/Page column 85
[26] Journal of Organic Chemistry, 2010, vol. 75, # 2, p. 518 - 521
[27] Helvetica Chimica Acta, 1996, vol. 79, # 8, p. 2137 - 2151
[28] Journal of Medicinal Chemistry, 2015, vol. 58, # 17, p. 6819 - 6843
[29] Beilstein Journal of Organic Chemistry, 2017, vol. 13, p. 644 - 647
[30] Journal of Labelled Compounds and Radiopharmaceuticals, 2007, vol. 50, # 7, p. 666 - 670
[31] Chemical Communications, 2006, # 20, p. 2156 - 2158
[32] Journal of Medicinal Chemistry, 2014, vol. 57, # 22, p. 9673 - 9686
[33] Patent: WO2017/96045, 2017, A1, . Location in patent: Paragraph 00883
[34] Tetrahedron Letters, 1997, vol. 38, # 33, p. 5741 - 5744
[35] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 21, p. 4828 - 4832
[36] Journal of Medicinal Chemistry, 2004, vol. 47, # 24, p. 6055 - 6069
[37] Journal of Medicinal Chemistry, 2005, vol. 48, # 11, p. 3832 - 3839
[38] Journal of the Chemical Society, Perkin Transactions 2, 2002, # 5, p. 923 - 927
[39] Tetrahedron Letters, 2004, vol. 45, # 38, p. 7081 - 7085
[40] Patent: US5965591, 1999, A,
[41] Patent: WO2003/105845, 2003, A1, . Location in patent: Page 88-89
[42] Patent: EP1602362, 2005, A1, . Location in patent: Page/Page column 50
[43] Patent: EP1607088, 2005, A1, . Location in patent: Page/Page column 53
[44] Biomacromolecules, 2012, vol. 13, # 5, p. 1632 - 1641
[45] Angewandte Chemie - International Edition, 2014, vol. 53, # 3, p. 883 - 887[46] Angew. Chem., 2013, vol. 53, # 3, p. 902 - 906
[47] Tetrahedron Letters, 2015, vol. 56, # 51, p. 7108 - 7111
[48] Patent: US2016/128945, 2016, A1, . Location in patent: Paragraph 0486; 0487; 0488
[49] Biomacromolecules, 2016, vol. 17, # 11, p. 3632 - 3639
[50] Journal of Medicinal Chemistry, 2017, vol. 60, # 16, p. 7067 - 7083
[51] Tetrahedron, 2016, vol. 72, # 41, p. 6492 - 6498
[52] Journal of Medicinal Chemistry, 2018, vol. 61, # 11, p. 4961 - 4977
[53] ChemMedChem, 2018, vol. 13, # 18, p. 1957 - 1971
  • 3
  • [ 85909-08-6 ]
  • [ 75178-87-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2009, vol. 48, # 7, p. 1324 - 1327
[2] Chemistry - An Asian Journal, 2018, vol. 13, # 17, p. 2559 - 2565
  • 4
  • [ 2508-29-4 ]
  • [ 24424-99-5 ]
  • [ 75178-87-9 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 20℃; for 2.5 h; The amino alcohol 21b (1.0 equiv, 2.87 mmol, 0.30 mL) was dissolved in 3 mL of CH2Cl2 ([21b] =0.5 mL/L), cooled in an ice bath and Boc2O (1.0 equiv, 2.87 mmol, 0.63 mL) was added. After stirring for 0.5 h at 0 °C, the cooling bath was removed and the mixture was allowed to stir for 2 h at ambient temperature. Subsequently, 3 mL of 1 N HCl solution (aq.) were added, the phases were separated,the organic layer was washed successively with 1 N HCl-, saturated NaHCO3 solution in water and brine/H2O 1:1 (each 3 mL) and dried over MgSO4. After concentration with 2 mL of chloroform under reduced pressure for two times and drying in high vacuum under stirring for 0.5 h delivered the carbamate 12c (2.99 mmol, quant., 567 mg) as a colorless oil.
Reference: [1] Beilstein Journal of Organic Chemistry, 2014, vol. 10, p. 369 - 383
  • 5
  • [ 57294-38-9 ]
  • [ 75178-87-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 3, p. 1376 - 1392
[2] Chemical and pharmaceutical bulletin, 1983, vol. 31, # 9, p. 3360 - 3362
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 24, p. 10257 - 10269
  • 6
  • [ 104700-36-9 ]
  • [ 75178-87-9 ]
  • [ 128490-08-4 ]
Reference: [1] Chemistry Letters, 1986, p. 815 - 818
  • 7
  • [ 67-56-1 ]
  • [ 85909-08-6 ]
  • [ 75178-87-9 ]
  • [ 85909-04-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2009, vol. 48, # 7, p. 1324 - 1327
  • 8
  • [ 85909-08-6 ]
  • [ 67-63-0 ]
  • [ 1140511-02-9 ]
  • [ 75178-87-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2009, vol. 48, # 7, p. 1324 - 1327
  • 9
  • [ 13325-10-5 ]
  • [ 34619-03-9 ]
  • [ 75178-87-9 ]
Reference: [1] Journal of the American Chemical Society, 2018, vol. 140, # 20, p. 6278 - 6287
  • 10
  • [ 24424-99-5 ]
  • [ 75178-87-9 ]
Reference: [1] Chemistry - An Asian Journal, 2018, vol. 13, # 17, p. 2559 - 2565
  • 11
  • [ 75178-87-9 ]
  • [ 33545-98-1 ]
Reference: [1] Synthesis, 1990, p. 366 - 368
  • 12
  • [ 865-33-8 ]
  • [ 75178-87-9 ]
  • [ 85909-04-2 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 19, p. 5072 - 5075
  • 13
  • [ 67-56-1 ]
  • [ 85909-08-6 ]
  • [ 75178-87-9 ]
  • [ 85909-04-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2009, vol. 48, # 7, p. 1324 - 1327
  • 14
  • [ 75178-87-9 ]
  • [ 85909-08-6 ]
Reference: [1] Chemistry--A European Journal, 2012, vol. 18, # 37, p. 11524 - 11527,4
  • 15
  • [ 75178-87-9 ]
  • [ 99207-32-6 ]
Reference: [1] Patent: JP2017/71567, 2017, A,
  • 16
  • [ 75178-87-9 ]
  • [ 164365-88-2 ]
YieldReaction ConditionsOperation in experiment
100% With carbon tetrabromide; triphenylphosphine In tetrahydrofuran for 3 h; Inert atmosphere tert-Butyl (4-hydroxybutyl)carbamate (1.06 g, 5.788 mmol) was dissolved in dry THF (54 ml) followed by addition of Ph3P (2.86 g, 10.92 mmol, 1.9 eq.). Then CBr4 (3.62 g, 10.92 mmol, 1.9 eq.) was slowly added to the mixture. After 3 h the solution was filtered through a celite pad to eliminate the by-products and washed with Et2O. The solvents were removed under high vacuum. The crude product was purified by flash chromatography on silica gel (hexane/EtOAc, 3:1) to give 9 as a white solid at 5°C (1.73 g, quantitative yield)
98% With carbon tetrabromide; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 4 h; To a solution of tert-butyl (4-hydroxybutyl)carbamate (5a) (1.0 g, 5.3 mmol) and PPh3 (2.09 g, 8 mmol) in 20 mL of THF, a solution of CBr4 (2.7 g, 8 mmol) in 10 mL of THF was added dropwise, under stirring, at 0 °C. The mixture was allowed to warm to room temperature and stirred for 4 h. The solvent was evaporated in vacuo, then the residue was purified by silica gel flash chromatography, eluting with hexanes, then hexanes/ethyl acetate, from 95/5 to 8/2, affording 1.31 g (5.2 mmol, 98percent yield) of pure, target product, as a colorless oil.‘H NMR (400 MHz, CDC13): = 4.54 (bs, 1 H); 3.44 (t, 2 H); 3.17-3.14 (m, 2 H); 1.92-1.87 (m, 2 H); 1.69-1.63 (m, 2 H); 1.46 (s, 9 H).
78% With carbon tetrabromide; triphenylphosphine In dichloromethane at 20℃; for 20 h; Inert atmosphere A solution of compound 07-4-1 (11.0 g, 58.1 mmol, 1.0 eq) in DCM (200 mL) were added CBr4 (39.5 g, 119.1 mmol, 2.05 eq) and PPh3 (32.9 g, 125.6 mmol, 2.16 eq) at 20°C, and the resulting mixture was stirred at 20°C for 20 h, diluted with water (100 mL) and extracted with DCM (100 mL*3) ,and the mixture was filtered and concentrated under reduced pressure to give a residue which was purified by column chromatography (SiO2) to give compound 07-4-2 (12.0 g, 45.2 mmol, 78percent yield).1H NMR (CDCl3, 400 MHz): δ 3.41 (t, J=6.62 Hz, 2 H), 3.14 (d, J=6.17 Hz, 2 H), 1.83 - 1.94 (m, 2 H), 1.62 (quin, J=7.28 Hz, 2 H), 1.36 - 1.49 (m, 9 H).
63.3% With carbon tetrabromide; triphenylphosphine In dichloromethane at 0 - 20℃; for 18 h; To an ice-cold solution of tert-butyl 4-hydroxybutylcarbamate (5 g, 26.41 mmol) in dichloromethane (200 mL) was added triphenylphosphine (10.38 g, 39.61 mmol) followed by carbon tetrabromide (13.15 g, 39.61 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 18 h. The solvent was removed under reduced pressure and the residue was purified by column chromatography (60-120 mesh silica gel) using 10percent ethyl acetate in pet-ether to give tert-butyl 4-bromobutylcarbamate(4.2 g, 63.3 percent) as a light green liquid. XH NMR (400 MHz, CDC13) δ ppm 4.53 (1H, s), 3.45-3.41 (2H, m), 3.18-3.13 (2H, m), 1.93-1.83 (2H, m), 1.68-1.61 (2H, m), 1.47 (9H, s).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1151 - 1155
[2] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 11, p. 1156 - 1161
[3] Patent: WO2017/53360, 2017, A1, . Location in patent: Paragraph 0154
[4] Patent: WO2017/96045, 2017, A1, . Location in patent: Paragraph 00884
[5] Patent: WO2012/9309, 2012, A1, . Location in patent: Page/Page column 58
[6] Journal of the Chemical Society - Series Chemical Communications, 1995, # 10, p. 1015 - 1016
[7] Journal of the Chemical Society, Perkin Transactions 2, 2002, # 5, p. 923 - 927
  • 17
  • [ 558-13-4 ]
  • [ 75178-87-9 ]
  • [ 164365-88-2 ]
YieldReaction ConditionsOperation in experiment
70% With triphenylphosphine In dichloromethane 7b)
tert-Butyl 4-bromobutylcarbamate
Carbon tetrabromide (5 g) was added at once to a solution of tert-butyl 4-hydroxybutylcarbamate (1.89 g) obtained in Example 7a) and triphenylphosphine (3.15 g) in methylene chloride (20 ml), and the mixture was further stirred at room temperature for 2 minutes.
The reaction mixture was washed by addition of saturated sodium bicarbonate water, followed by further washing with saturated brine.
The extract was concentrated, and the residue was purified by silica gel column to obtain the title compound as colorless oil (1.76 g, 70percent).
NMR (CDCl3) δ: 1.46 (9H, s), 1.50-2.00 (4H, m), 3.08-3.12 (2H, m), 3.43 (2H, t, J=6.6).
Reference: [1] Patent: US2003/187023, 2003, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 75178-87-9 ]

Amino Acid Derivatives

Chemical Structure| 58885-58-8

[ 58885-58-8 ]

Boc-β-Ala-ol

Similarity: 0.90

Chemical Structure| 57294-38-9

[ 57294-38-9 ]

Boc-GABA-OH

Similarity: 0.88

Chemical Structure| 27219-07-4

[ 27219-07-4 ]

Boc-5-Ava-OH

Similarity: 0.86

Chemical Structure| 60142-89-4

[ 60142-89-4 ]

7-((tert-Butoxycarbonyl)amino)heptanoic acid

Similarity: 0.86

Chemical Structure| 10436-25-6

[ 10436-25-6 ]

Boc-11-aminoundecanoic acid

Similarity: 0.86